About
EQT Life Sciences, formerly LSP, is identified as one of Europe’s largest and most experienced Life Sciences investors with a 30-year history. The firm targets innovative companies focusing on the development of therapeutics, medical devices, diagnostics, and healthtech globally. EQT Life Sciences has raised around 3.5 billion euros across 12 private funds and 3 investment strategies. Their team comprises highly experienced investment professionals with backgrounds in medicine and science, aiming to back inventors with ideas that could improve patient outcomes.
Sign up to see Drew Burdon's full profile
Access investment thesis, focus areas, bio, and contact details for Drew Burdon and 22,000+ other VC professionals.
EQT Life Sciences
Amsterdam, NL